Anti-IL-5 and anti-IL-5Rα in real-life studies have shown to significantly reduce eosinophils number in nasal polyps, the latter with a complete reduction in eosinophils- and neutrophils-infiltrated cells, with a significant reduction in the nasal polyp score (NPS) after 6 months [118]. This evidence concerns the gene IL5 and nasal cavity polyp.